Fujifilm Cellular Dynamics rolls out iCell Blood-Brain Barrier Isogenic Kit
Available commercially by the end of June, the iCell Blood-Brain Barrier Isogenic Kit is an off-the-shelf, ready-to-use cell…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
02 Jun 23
Available commercially by the end of June, the iCell Blood-Brain Barrier Isogenic Kit is an off-the-shelf, ready-to-use cell…
01 Jun 23
Researchers trained a computer model to understand the connections between thousands of genes—and pinpoint how those connections go…
31 May 23
The drug discovery partnership will make use of XtalPi’s integrated AI capabilities and robotics platform to design and…
31 May 23
The platform enables a research strategy that uses Kiyatec's capacity to correctly dissociate and characterise primary patient tissues…
10 May 23
Founded in 2021, XinThera is aiming to develop small molecule drugs for the treatment of cancer and immunologic…
03 May 23
Under the agreement, Lundbeck will have access to Alloy Therapeutics’ antibody discovery services as well as its SeqImmune…
01 Dec 22
Under the collaboration, the two companies will jointly develop several small molecule programmes, primarily targeting immune modulation in…
17 Oct 22
The funding will help to generate new treatments and improve the delivery of healthcare services to support experimental…
14 Oct 22
The new financing will allow Odyssey Therapeutics to advance its portfolio of precision immunomodulators and oncology medicines, supporting…
12 Oct 22
The strategic research collaboration will combine Illumina and AstraZeneca’s combined strengths in artificial intelligence (AI) based genome interpretation…